(b)(4).This report is related to a journal article, therefore no product will be returned for analysis and the batch history records cannot be reviewed as the lot/batch number has not been provided.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
Title: expanded indication for magnetic sphincter augmentation: outcomes in weakly acidic reflux compared to standard gerd patients authors: milena nikolic, aleksa matic, joy feka, lisa gensthaler, ivan kristo, bogdan osmokrovic, franz m.Riegler, berta o.Mosleh, sebastian f.Schoppmann citation: journal of gastrointestinal surgery (2021).Https://doi.Org/10.1007/s11605-021-05152-5 the aim of this retrospective review study of a prospectively collected clinical database was to evaluate the long-term postoperative outcomes of patients with preoperative weakly acidic/biliary reflux undergoing msa in a high-volume specialized reflux center.Between 2012 to 2020, a total of 268 patients who underwent magnetic sphincter augmentation (msa) for chronic gastroesophageal reflux disease were included in the study.Of these, 67 patients (36 male and 31 female; median age of 44 years; median bmi of 25) were found to have weakly acidic reflux, while 201 (137 male and 64 female; median age of 51 years; median bmi of 25.5) revealed acidic reflux in the preoperative 24-h impedance-ph-metry.Surgery was performed using the msa device (linx® reflux management system; torax medical, maple grove, mn).The median follow-up time for patients with weakly acidic reflux and acidic reflux was 24 months (iqr, 31) and 22 months (iqr, 24), respectively.Reported complications include gas bloating syndrome (n=16); inability to belch/vomit (n=?); heartburn (n=?); regurgitation (n=?); chronic cough/respiratory symptoms (n=?); rarely difficulties swallowing with solids only (n=68) and occasional difficulties swallowing with solids (n=30) which was successfully managed by endoscopic balloon dilatation in 3 patients; continued use of proton pump inhibitor postoperatively (n=10%); unclear pain in the chest area (n=2) requiring explant of the msa device.In conclusion, msa leads to a significant reduction in daily, bothersome gerd symptoms, with low postoperative morbidity and increase in gerd-related quality of life, as well as alimentary satisfaction in patients with weakly acidic reflux.Furthermore, the importance of a preoperative 24-h impedance-ph-metry in detecting patients with weakly acidic reflux, who would benefit from msa, should not be underestimated.
|